Aller au contenu principal
Profil bibliographique

Weihong Song

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

22Publications signalées
790Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Diabetes Treatment and ManagementMetabolism, Diabetes, and CancerDiabetes Management and ResearchPancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Les publications récentes

2025 article OpenAlex

Efficacy and safety of chiglitazar add‐on to metformin in type 2 diabetes mellitus ( RECAM study)

Leili Gao, Linong Ji, Xin Yan, Zhifeng Cheng et autres

AIMS: Chiglitazar is a novel peroxisome proliferator-activated receptor pan-agonist regulating glucose and lipid metabolism. The RECAM study aimed to evaluate the efficacy and safety of chiglitazar add-on therapy to metformin in patients with type 2 diabetes mellitus (T2DM). MATERIALS AND METHODS: In …

cn (code pays fourni par la source)

3 citations Diabetes Obesity and Metabolism
Accès ouvert 2025 article OpenAlex

Smoking impairs cognitive function through the mediating effect of periodontitis in older adults

Xiaoqian Luan, Jin Zhou, Jin Li, Yao An et autres

OBJECTIVES: Evidence has shown that both smoking and periodontitis were linked to cognitive impairment. This study examines whether periodontitis mediates the effects of smoking status on cognitive function in older adults. METHODS: Using data from the National Health and Nutrition Examination Survey …

cn (code pays fourni par la source)

3 citations BMC Psychiatry
2025 article OpenAlex

One-pot three-component synthesis of benzo[ h ]isoquinolin-3-ones via rhodium( iii )-catalyzed C–H activation

Weihong Song, Xiaomei Jiang, Weiguo Yu, Ziwei Xiang

A Rh( iii )-catalyzed synthesis of unprecedented benzo[ h ]isoquinolin-3-ones from 1-naphthaldehyde, aniline and diazo compounds in one pot has been realized with an imine as the directing group which was generated from aldimine condensation in situ .

cn, cz (code pays fourni par la source)

1 citation Organic & Biomolecular Chemistry
2024 article OpenAlex

A biweekly DPP ‐4 inhibitor cofrogliptin monotherapy in Chinese patients with impaired glucose tolerance: A phase 2, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial

Qinghua He, Zhifeng Cheng, Yufeng Li, Xiaoyan Xing et autres

Abstract Aims To assess the efficacy and safety of cofrogliptin for impaired glucose tolerance (IGT). Methods In this multicenter, double‐blind, placebo‐controlled phase 2 trial, IGT patients were randomized 1:1:1 to receive cofrogliptin 10 mg, cofrogliptin 25 mg or placebo once biweekly. The …

cn (code pays fourni par la source)

2 citations Diabetes Obesity and Metabolism
Accès ouvert 2024 article OpenAlex

SLC44A2-mediated phenotypic switch of vascular smooth muscle cells contributes to aortic aneurysm

Mengen Xing, Wanqi Chen, Yachen Ji, Weihong Song

The phenotypic switch of vascular smooth cells (VSMCs) from a contractile to a synthetic state is associated with the development and progression of aortic aneurysm (AA). However, the mechanism underlying this process remains unclear. In this issue of the JCI, Song et …

cn (code pays fourni par la source)

15 citations Journal of Clinical Investigation
Accès ouvert 2024 article OpenAlex

Alpha-lipoic acid alleviates cognitive deficits in transgenic APP23/PS45 mice through a mitophagy-mediated increase in ADAM10 α-secretase cleavage of APP

Jie Zhang, Yanshuang Jiang, Xiangjun Dong, Zijun Meng et autres

BACKGROUND: Alpha-lipoic acid (ALA) has a neuroprotective effect on neurodegenerative diseases. In the clinic, ALA can improve cognitive impairments in patients with Alzheimer's disease (AD) and other dementias. Animal studies have confirmed the anti-amyloidosis effect of ALA, but its underlying mechanism remains …

cn (code pays fourni par la source)

19 citations Alzheimer s Research & Therapy
2024 article OpenAlex

733-P: Efficacy and Safety of HS-20094 in Patients with Type 2 Diabetes—A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial

Lin Liu, XIAOXIA SHI, Fei He, Zhifeng Cheng et autres

Introduction and Objective: HS-20094 is a novel dual GIP and GLP-1 receptor agonist. A 4-week POC study was conducted to assess the preliminary efficacy and safety of HS-20094 in patients with type 2 diabetes (T2DM). Methods: This was a randomized, double-blind, placebo-controlled …

1 citation Diabetes

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.